EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Investigating rates and risk factors for hepatitis C virus reinfection in people receiving antiviral treatment in England

Matthew Hibbert, Ruth Simmons, Helen Harris, Monica Desai, Caroline A Sabin, Sema Mandal

Journal of Viral Hepatitis · 2023

DOI: 10.1111/jvh.13835 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Viral Hepatitis, 2023. Verfasst von Matthew Hibbert und 5 weiteren Autor:innen. Beteiligte Einrichtung: Blood Safety, Hepatitis, Sexually Transmitted Infections and HIV Division, UK Health Security Agency (UKHSA), London, UK. Hauptthemen laut MEDLINE: Substance Abuse, Intravenous, Hepatitis C, Hepatitis C, Chronic. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Health, National Institute for Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

England has committed to the World Health Organization target to eliminate hepatitis C virus (HCV) as a public threat by the year 2030. Given successful treatments for HCV in recent years, it is unclear whether HCV reinfection will impact England's ability to achieve HCV elimination. We aimed to estimate the HCV reinfection rate among a cohort of patients receiving antiviral treatment using available surveillance data. Linkage between a treatment dataset from 2015 to 2019 and an HCV RNA testing dataset were used to identify people who experienced reinfection using three criteria. A Cox proportional hazards model was used to determine risk factors associated with HCV reinfection among a cohort who received treatment and had follow‐up HCV RNA testing. The reinfection rate among those receiving HCV treatment was 7.91 per 100 person‐years (PYs, 95% confidence interval (CI) 7.37–8.49) and highest among current injecting drug users (22.55 per 100 PYs, 95% CI 19.98–25.46) and people who had been in prison (20.42 per 100 PYs, 95% CI 17.21–24.24). In the adjusted model, women had a significantly reduced risk of reinfection. Being of younger age, current injecting drug users, and receipt of first treatment in prison were each significantly associated with increased risk of reinfection. Two‐fifths of those with reinfection (43%, n = 329/767) were linked to treatment after reinfection, and of those starting treatment, three quarters (75%, n = 222/296) achieved a sustained virologic response. Guidance for testing groups at risk of reinfection and harm reduction strategies to minimize transmission should be implemented if England is to achieve HCV elimination targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Substance Abuse, IntravenousHepatitis CHepatitis C, ChronicHumansFemaleHepacivirusReinfectionRecurrenceRisk FactorsRNAAntiviral Agents

Stichwörter der Autor:innen

eliminationhepatitis Cpeople who inject drugsreinfectiontreatment

Substanzen

RNAAntiviral Agents

Autor:innen und Institutionen

  • Blood Safety, Hepatitis, Sexually Transmitted Infections and HIV Division, UK Health Security Agency (UKHSA), London, UK.
  • National Institute for Health and Care Research Health Protection Research Unit (NIHR HPRU) in Blood Borne and Sexually Transmitted Infections at University College London in partnership with UKHSA, London, UK.
  • Institute for Global Health, University College London, London, UK.

Förderung

  • Department of Health
  • National Institute for Health Research

Zitieren

APA

Hibbert, M., Simmons, R., Harris, H., Desai, M., Sabin, C. A., & Mandal, S. (2023). Investigating rates and risk factors for hepatitis C virus reinfection in people receiving antiviral treatment in England. Journal of Viral Hepatitis. https://doi.org/10.1111/jvh.13835

Vancouver

Hibbert M, Simmons R, Harris H, Desai M, Sabin CA, Mandal S. Investigating rates and risk factors for hepatitis C virus reinfection in people receiving antiviral treatment in England. Journal of Viral Hepatitis. 2023. doi:10.1111/jvh.13835

BibTeX
@article{Hibbert2023,
  author = {Hibbert, Matthew and Simmons, Ruth and Harris, Helen and Desai, Monica and Sabin, Caroline A and Mandal, Sema},
  title = {Investigating rates and risk factors for hepatitis C virus reinfection in people receiving antiviral treatment in England},
  journal = {Journal of Viral Hepatitis},
  year = {2023},
  doi = {10.1111/jvh.13835}
}
Kostenlos starten →